Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features.
De Pascale G, Pintaudi G, Lisi L, De Maio F, Cutuli SL, Tanzarella ES, Carelli S, Lombardi G, Cesarano M, Gennenzi V, Ciotti GMP, Grieco DL, Posteraro B, Sanguinetti M, Navarra P, Antonelli M.
De Pascale G, et al. Among authors: navarra p.
Antibiotics (Basel). 2023 Jan 9;12(1):125. doi: 10.3390/antibiotics12010125.
Antibiotics (Basel). 2023.
PMID: 36671325
Free PMC article.